You are now accessing the company's Annual Report 2005
GlaxoSmithKline plc is an English public limited company. Its shares are listed on the London Stock Exchange and the New York Stock Exchange.
This report is the Annual Report of the company for the full year ended 31 December 2005. The Annual Report was approved by the Board of Directors on 1 March 2006.
A summary report on the year, the Annual Review is intended for the investor not needing the full detail of the Annual Report and is produced as a separate document. The Annual Review includes the joint statement by the Chairman and the Chief Executive Officer, a summary review of operations and summary financial statements.
The Annual Review is issued to all shareholders. The Annual Report is issued additionally to those shareholders who, by electing to receive the full Annual Report as well as the summary Annual Review, have indicated that they require more detailed financial reporting.
Cautionary statement regarding forward-looking statements
Under the 'safe harbor' provisions of the US Private Securities Litigation Reform Act of 1995, the company cautions investors that any forward-looking statements or projections made by the company, including those made in the Annual Report, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Factors that may affect the Group's operations are described under 'Risk factors' in the ‘Operating and Financial Review and Prospects’ section of the company's Annual Report for 2005 on Form 20-F filed with the US Securities and Exchange Commission.
Updated 3 March 2006 - © 2006 GlaxoSmithKline - All Rights Reserved
Back to top